IM Cannabis names Ronen Zalayet CEO, succeeding Oren Shuster
IMCC•IM Cannabis appointed Nexera Technologies CFO Ronen Zalayet CEO effective November 19, 2026, succeeding Oren Shuster, who also resigned from the board and as CEO of Israeli subsidiary Focus Medical Herbs. Shakked Shuster became Focus Medical Herbs CEO, and Ohad Melnik joined the board as an independent director.
1. Leadership changes
IM Cannabis appointed Ronen Zalayet CEO effective November 19, 2026, succeeding Oren Shuster. Shuster also resigned from the board and as CEO of Israeli subsidiary Focus Medical Herbs; Shakked Shuster, formerly head of product and marketing, became Focus Medical Herbs CEO. Ohad Melnik became an independent director, filling the vacancy left by Einat Zakariya’s September 2026 resignation. Melnik served as a Formula Systems director from January 2019 to May 2024.




